Key Insights

Highlights

Success Rate

50% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 65/100

Termination Rate

25.0%

2 terminated out of 8 trials

Success Rate

50.0%

-36.5% vs benchmark

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

150%

3 of 2 completed with results

Key Signals

3 with results50% success

Data Visualizations

Phase Distribution

5Total
Not Applicable (4)
P 4 (1)

Trial Status

Terminated2
Recruiting2
Completed2
Active Not Recruiting1
Suspended1

Trial Success Rate

50.0%

Benchmark: 86.5%

Based on 2 completed trials

Clinical Trials (8)

Research Network

Activity Timeline